ESR2 and cancer: The observation that decreased PR expression in cancer associated stroma is similar to what was reported with other steroid receptors such as AR and ER-β [34]–[36], suggesting a general principle that loss of steroid receptors may be required for prostate stroma to be re-activated and to build a supportive microenvironment for PCa.